Lactate/GPR81 recruits regulatory T cells by modulating CX3CL1 to promote immune resistance in a highly glycolytic gastric cancer

• Published in: Oncoimmunology Vol. 13; no. 1; p. 2320951
• Main Authors: Su, Jin, Mao, Xinyuan, Wang, Lingzhi, Chen, Zhian, Wang, Weisheng, Zhao, Cuiyin, Li, Guoxin, Guo, Weihong, Hu, Yanfeng
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 2024; Taylor & Francis Group
• Subjects: Animals; Chemokine CX3CL1; Gastric cancer; Humans; immune resistance; lactate; Lactic Acid - metabolism; Lactic Acid - pharmacology; Mice; Original Research; Receptors, G-Protein-Coupled - genetics; Receptors, G-Protein-Coupled - metabolism; regulatory T cells; Stomach Neoplasms; T-Lymphocytes, Regulatory - metabolism; Tumor Microenvironment; regulatory T cells; tumor microenvironment; lactate; Gastric cancer; immune resistance
• ISSN: 2162-402X; 2162-4011; 2162-402X
• DOI: 10.1080/2162402X.2024.2320951

Lactate plays an important role in shaping immune tolerance in tumor microenvironment (TME) and correlates with poor prognosis in various solid tumors. Overcoming the immune resistance in an acidic TME may improve the anti-tumor immunity. Here, this study elucidated that via G-protein-coupled receptor 81 (GPR81), lactate could modulate immune tolerance in TME by recruiting regulatory T cells (Tregs) in vitro and in vivo. A high concentration of lactate was detected in cell supernatant and tissues of gastric cancer (GC), which was modulated by lactic dehydrogenase A (LDHA). GPR81 was the natural receptor of lactate and was overexpressed in different GC cell lines and samples, which correlated with poor outcomes in GC patients. Lactate/GPR81 signaling could promote the infiltration of Tregs into TME by inducing the expression of chemokine CX3CL1. GPR81 deficiency could decrease the infiltration of Tregs into TME, thereby inhibiting GC progression by weakening the inhibition of CD8 T cell function in a humanized mouse model. In conclusion, targeting the lactate/GPR81 signaling may potentially serve as a critical process to overcome immune resistance in highly glycolytic GC.